China SXT Pharmaceuticals, Inc. SXTC 0.70 China SXT Pharmaceuticals, Inc.

Home
⇒ 
Stock List ⇒ China SXT Pharmaceuticals, Inc.
Range:0.53-6.39Vol Avg:662912Last Div:0Changes:-0.01
Beta:1.13Cap:0.00BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Fri Jan 04 2019Empoloyees:75
CUSIP:G2161P108CIK:0001723980ISIN:VGG2161P1403Country:CN
CEO:Mr. Feng ZhouWebsite:https://www.sxtchina.com
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow